Search Results 81-90 of 11505 for Cirrhosis
The purpose of this study is to define the determinants of cirrhosis progression using clinical and specialized biomarkers over time in North America through a ...
Mayo Clinic researchers are committed to improving diagnosis and treatment of cirrhosis of the liver. Mayo researchers were among the first to identify ...
Research. Mayo Clinic researchers are committed to improving diagnosis and treatment of cirrhosis of the liver. Mayo researchers were among the first to ...
Untreated autoimmune hepatitis can lead to scarring of the liver, called cirrhosis. It can also eventually lead to liver failure. When diagnosed and treated ...
Cirrhosis makes it hard for blood to flow through the liver. The causes of portal hypertension can be grouped by where the blockage or slowing of blood flow ...
The purpose of this study is to evaluate the outcome of hospitalization related to the presence of cirrhosis. We are participating in optional blood, saliva ...
... cirrhosis. Hepatic encephalopathy occurs in 30% to 40% of people who have cirrhosis. Alcohol use, infections, use of some medicines and blood clots in the ...
People with a serious liver condition such as cirrhosis or metabolic dysfunction-associated steatotic liver disease are more likely to react to toxins. Having ...
This artificial intelligence-based noninvasive tool enhances current prognostic models and may improve risk stratification in cirrhosis management.
... cirrhosis. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.